Eran Elinav
#104,063
Most Influential Person Now
Israeli immunologist
Eran Elinav's AcademicInfluence.com Rankings
Eran Elinavbiology Degrees
Biology
#6369
World Rank
#9066
Historical Rank
Immunology
#374
World Rank
#388
Historical Rank
Download Badge
Biology
Eran Elinav's Degrees
- PhD Immunology Weizmann Institute of Science
Why Is Eran Elinav Influential?
(Suggest an Edit or Addition)According to Wikipedia, Eran Elinav is an Israeli immunologist and microbiota researcher at the Weizmann Institute of Science and the DKFZ. He is an international scholar at the Howard Hughes Medical Institute and the Bill & Melinda Gates Foundation and a senior fellow of the Canadian Institute for Advance Research .
Eran Elinav's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity (2012) (2001)
- Inflammasomes in health and disease (2012) (1873)
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis (2011) (1702)
- Personalized Nutrition by Prediction of Glycemic Responses (2015) (1621)
- Environment dominates over host genetics in shaping human gut microbiota (2018) (1562)
- Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms (2013) (1448)
- Artificial sweeteners induce glucose intolerance by altering the gut microbiota (2014) (1428)
- The microbiome and innate immunity (2016) (1238)
- Interaction between microbiota and immunity in health and disease (2020) (1080)
- Transkingdom Control of Microbiota Diurnal Oscillations Promotes Metabolic Homeostasis (2014) (853)
- Dysbiosis and the immune system (2017) (851)
- Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features (2018) (827)
- Microglia development follows a stepwise program to regulate brain homeostasis (2016) (794)
- Intestinal lamina propria dendritic cell subsets have different origin and functions. (2009) (766)
- You are what you eat: diet, health and the gut microbiota (2018) (719)
- Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling (2015) (636)
- Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT (2018) (620)
- NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion (2014) (539)
- The pros, cons, and many unknowns of probiotics (2019) (509)
- Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations (2016) (491)
- Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner (2019) (480)
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection (2018) (468)
- Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation (2017) (451)
- The intestinal microbiota fuelling metabolic inflammation (2019) (434)
- The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome (2016) (409)
- Diet–microbiota interactions and personalized nutrition (2019) (391)
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4 (2010) (384)
- Our Gut Microbiome: The Evolving Inner Self (2017) (368)
- Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis (2015) (358)
- Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples (2015) (336)
- Potential roles of gut microbiome and metabolites in modulating ALS in mice (2019) (336)
- Regulation of the antimicrobial response by NLR proteins. (2011) (330)
- Persistent microbiome alterations modulate the rate of post-dieting weight regain (2016) (323)
- The role of the microbiome in NAFLD and NASH (2018) (282)
- Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer (2013) (269)
- Metabolites: messengers between the microbiota and the immune system (2016) (267)
- Microbiome, metabolites and host immunity. (2017) (267)
- Use of Metatranscriptomics in Microbiome Research (2016) (265)
- Microbiome-Modulated Metabolites at the Interface of Host Immunity (2017) (235)
- Inflammasome activation and regulation: toward a better understanding of complex mechanisms (2020) (232)
- Bile acids in glucose metabolism in health and disease (2018) (231)
- The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury (2016) (224)
- Nuclear Retention of mRNA in Mammalian Tissues (2015) (214)
- IL-22 Deficiency Alters Colonic Microbiota To Be Transmissible and Colitogenic (2013) (214)
- Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses. (2017) (209)
- The Role of the Immune System in Metabolic Health and Disease. (2017) (185)
- Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease. (2016) (181)
- Inflammasomes: far beyond inflammation (2012) (175)
- Non-alcoholic fatty liver and the gut microbiota (2016) (165)
- The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs (2019) (155)
- Vaginal microbiome transplantation in women with intractable bacterial vaginosis (2019) (147)
- Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome (2020) (141)
- Role of the intestinal microbiome in liver disease. (2013) (140)
- Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations Graphical (2016) (139)
- Non-caloric artificial sweeteners and the microbiome: findings and challenges (2015) (138)
- NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells (2012) (137)
- Integration of Innate Immune Signaling. (2016) (137)
- Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. (2006) (136)
- The cross talk between microbiota and the immune system: metabolites take center stage. (2014) (135)
- and Metabolic Disease (2014) (135)
- Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. (2008) (132)
- Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor. (2009) (127)
- Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. (2007) (126)
- Development and Characterization of High Affinity Leptins and Leptin Antagonists* (2010) (123)
- The cancer microbiome (2019) (122)
- Microbiome at the Frontier of Personalized Medicine (2017) (118)
- The interplay between the innate immune system and the microbiota. (2014) (117)
- Inflammasome activation and regulation: toward a better understanding of complex mechanisms (2020) (110)
- Inflammasomes and metabolic disease. (2014) (109)
- The Fire Within: Microbes Inflame Tumors (2014) (109)
- Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping (2006) (107)
- Correlation Between Serum Alanine Aminotransferase Activity and Age: An Inverted U Curve Pattern (2005) (103)
- Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. (2009) (95)
- Integrative inflammasome activity in the regulation of intestinal mucosal immune responses (2012) (92)
- Low Alanine Aminotransferase Activity in Older People Is Associated with Greater Long‐Term Mortality (2006) (91)
- NLRP6: A Multifaceted Innate Immune Sensor. (2017) (90)
- Towards utilization of the human genome and microbiome for personalized nutrition. (2018) (85)
- The path towards microbiome-based metabolite treatment (2017) (84)
- Microbiome and cancer. (2021) (84)
- Low dose warfarin treatment for calcinosis in patients with systemic sclerosis (2004) (83)
- Reporting guidelines for human microbiome research: the STORMS checklist (2021) (82)
- The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome (2021) (78)
- High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function. (2020) (73)
- Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function (2009) (71)
- The gut microbiome and hypertension (2017) (71)
- Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. (2005) (71)
- The gut microbiome in human immunodeficiency virus infection (2016) (69)
- Moving from probiotics to precision probiotics (2020) (68)
- Inflammasomes and intestinal inflammation (2017) (67)
- The microbiota programs DNA methylation to control intestinal homeostasis and inflammation (2020) (64)
- Improvement in cholesterol emboli syndrome after iloprost therapy (2002) (64)
- Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome (2015) (64)
- Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation (2022) (60)
- Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner (2021) (60)
- Acute liver failure is regulated by MYC- and microbiome-dependent programs (2020) (58)
- The microbiome in anti-cancer therapy. (2017) (58)
- A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host (2015) (57)
- IL-23–producing IL-10Rα–deficient gut macrophages elicit an IL-22–driven proinflammatory epithelial cell response (2019) (57)
- Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome (2019) (56)
- Diet Diurnally Regulates Small Intestinal Microbiome-Epithelial-Immune Homeostasis and Enteritis (2020) (56)
- XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis (2021) (55)
- Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer (2011) (55)
- The intestinal microbiota in chronic liver disease. (2013) (54)
- GAS6 is a key homeostatic immunological regulator of host–commensal interactions in the oral mucosa (2017) (53)
- Mutual interplay between IL-17–producing γδT cells and microbiota orchestrates oral mucosal homeostasis (2019) (52)
- Licorice consumption causing severe hypokalemic paralysis. (2003) (51)
- Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo (2017) (51)
- Microbiome diurnal rhythmicity and its impact on host physiology and disease risk (2019) (51)
- Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial (2018) (49)
- Role of the microbiome in non-gastrointestinal cancers. (2016) (48)
- Amelioration of non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver‐extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL‐10 levels (2006) (47)
- Phages and their potential to modulate the microbiome and immunity (2020) (47)
- Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. (2006) (47)
- Sieving through gut models of colonization resistance (2018) (46)
- Fatal voluntary salt intake resulting in the highest ever documented sodium plasma level in adults (255 mmol L−1): a disorder linked to female gender and psychiatric disorders (2004) (46)
- Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding. (2009) (45)
- Circadian Coordination of Antimicrobial Responses. (2017) (44)
- The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. (2005) (43)
- Transforming medicine with the microbiome (2019) (40)
- Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells (2016) (40)
- Near-fatal amitraz intoxication: the overlooked pesticide. (2005) (39)
- Personalized microbiome‐based approaches to metabolic syndrome management and prevention (2017) (38)
- Suppression of hepatocellular carcinoma by transplantation of ex‐vivo immune‐modulated NKT lymphocytes (2005) (38)
- A simple cage-autonomous method for the maintenance of the barrier status of germ-free mice during experimentation (2014) (38)
- Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis (2018) (38)
- Taming the inflammasome (2015) (37)
- Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome (2020) (37)
- Immune-Microbiota Interplay and Colonization Resistance in Infection. (2020) (36)
- Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance (2022) (36)
- Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation (2018) (36)
- Probiotics in the next-generation sequencing era (2020) (34)
- The anti‐inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota (2018) (34)
- Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis. (2021) (32)
- Postbiotics — when simplification fails to clarify (2021) (31)
- Inflammasomes and the microbiota—partners in the preservation of mucosal homeostasis (2014) (31)
- Analysis of microbiota alterations in inflammasome-deficient mice. (2013) (30)
- The Gut Microbiome and Individual-Specific Responses to Diet (2020) (30)
- Citrobacter rodentium Relies on Commensals for Colonization of the Colonic Mucosa (2017) (30)
- The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS) (2021) (30)
- Personalized Postprandial Glucose Response–Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes (2021) (29)
- Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target. (2019) (29)
- Role of the microbiome in the normal and aberrant glycemic response (2016) (29)
- Circadian Influences of Diet on the Microbiome and Immunity. (2020) (29)
- The microbiome and cytosolic innate immune receptors (2020) (29)
- Harnessing nanomedicine for mucosal theranostics--a silver bullet at last? (2013) (28)
- The NLRP6 inflammasome (2020) (27)
- Machine learning in clinical decision making. (2021) (26)
- Nutrition Regulates Innate Immunity in Health and Disease. (2020) (24)
- The remedy within: will the microbiome fulfill its therapeutic promise? (2017) (24)
- Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation. (2006) (23)
- The spatiotemporal program of zonal liver regeneration following acute injury. (2022) (22)
- Translating microbiome futures (2018) (22)
- Gut microbiota modulates weight gain in mice after discontinued smoke exposure (2021) (20)
- It's in the Milk: Feeding the Microbiome to Promote Infant Growth. (2016) (20)
- Environmental factors dominate over host genetics in shaping human gut microbiota composition (2017) (20)
- Maturation of the neonatal oral mucosa involves unique epithelium-microbiota interactions. (2020) (20)
- Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis (2004) (19)
- REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY (2004) (18)
- Novel superactive leptin antagonists and their potential therapeutic applications. (2014) (18)
- Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions (2015) (18)
- Constrictive Pericarditis Complicating Endovascular Pacemaker Implantation (2002) (18)
- The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses (2018) (18)
- Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis. (2002) (17)
- NLRP6 inflammasome is a regulator of colonic microbial ecology and risk for colitis (2013) (17)
- NLRP6 and Dysbiosis: Avoiding the Luring Attraction of Over-Simplification. (2018) (16)
- CCL2 (pM levels) as a therapeutic agent in inflammatory bowel disease models in mice (2010) (16)
- Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial (2022) (15)
- Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect (2020) (14)
- Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease (2019) (14)
- Exploring new horizons in microbiome research. (2014) (12)
- Personalized Nutrition: Are We There Yet? (2019) (12)
- Commensal inter-bacterial interactions shaping the microbiota. (2021) (12)
- Harnessing the microbiota for therapeutic purposes (2019) (12)
- Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus (2004) (11)
- POEMS syndrome: failure of newly suggested diagnostic criteria to anticipate the development of the syndrome. (2005) (10)
- Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis. (2007) (10)
- Inflammasome-mediated dysbiosis regulatesprogressionofNAFLDandobesity (2012) (9)
- Microbiome genomics for cancer prediction (2020) (9)
- Breakthroughs and Bottlenecks in Microbiome Research. (2021) (9)
- Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis (2022) (8)
- Episodic Macroglossia as the Sole Manifestation of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema (2004) (8)
- Utilization of Murine Laparoscopy for Continuous In-Vivo Assessment of the Liver in Multiple Disease Models (2009) (8)
- NFIL-trating the Host Circadian Rhythm-Microbes Fine-Tune the Epithelial Clock. (2017) (8)
- Time‐limited diets and the gut microbiota in cardiometabolic disease (2022) (8)
- Harnessing SmartPhones to Personalize Nutrition in a Time of Global Pandemic (2021) (7)
- Post-dieting weight gain: the role of persistent microbiome changes. (2017) (7)
- Dimensionality reduction of longitudinal ’omics data using modern tensor factorizations (2021) (6)
- Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin (2020) (6)
- Utilization of Host and Microbiome Features in Determination of Biological Aging (2022) (6)
- Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients (2021) (6)
- Diet–microbiota interactions and personalized nutrition (2019) (5)
- Antibiotic Therapy and Low Gut Microbiome Diversity Is Associated with Decreased Response and High Toxicity in BCP-ALL and DLBCL Patients after Treatment with CD19. CAR T-Cells (2020) (5)
- Corrigendum: NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells (2015) (5)
- Preparation and characterization of mouse IL-22 and its four single-amino-acid muteins that act as IL-22 receptor-1 antagonists. (2012) (5)
- Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation:A mere coincidence? (2006) (4)
- Microbiome-phage interactions in inflammatory bowel disease. (2022) (4)
- Gut microbiome and its potential link to personalized nutrition (2021) (4)
- A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy (2023) (4)
- Integration of Innate Immune (2016) (4)
- Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice (2020) (4)
- NF-κB Regulation by NLRs: T Cells Join the Club. (2015) (4)
- Antibiotic prophylaxis for bacterial infections in cirrhotic patients with ascites (2004) (3)
- Walk on the wildling side (2019) (3)
- Smoking-induced microbial dysbiosis in health and disease (2022) (3)
- Herbalife revisited: Reply (2008) (3)
- Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu) necessitate a full colonic visualization? (2004) (3)
- Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells (2019) (3)
- Embrace the fat when getting old (2019) (3)
- COVID-19 severity and complications associated with low diversity, dysbiosis and predictive metagenome features of the oropharyngeal microbiome. (2021) (3)
- Publisher Correction: Gut microbiota modulates weight gain in mice after discontinued smoke exposure (2022) (3)
- Our Microbiome: On the Challenges, Promises, and Hype. (2020) (3)
- The proteasome regulator PSME4 drives immune evasion and abrogates anti-tumor immunity in NSCLC (2021) (2)
- High-Throughput Screen Identi fi es Host and Microbiota Regulators of Intestinal Barrier Function (2020) (2)
- Herbalife nutritional products and liver injury revisited (2017) (2)
- The Microbiota: A New Player in the Etiology of Colorectal Cancer (2014) (2)
- Toward a better understanding of intermittent fasting effects: Ramadan fasting as a model. (2021) (2)
- The spatio-temporal program of liver zonal regeneration (2021) (2)
- Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice (2019) (2)
- The pros, cons, and many unknowns of probiotics (2019) (2)
- Epithelial Nlrp10 inflammasome mediates protection against intestinal autoinflammation (2023) (1)
- When Cultures Meet: The Landscape of "Social" Interactions between the Host and Its Indigenous Microbes. (2019) (1)
- SEPTEMBER 10, 2018 CLINICAL EVIDENCE AND NOT MICROBIOTA OUTCOMES DRIVE VALUE OF PROBIOTICS (2018) (1)
- UK Court decision: health care and immigration (2008) (1)
- Local and systemic effects of microbiome‐derived metabolites (2022) (1)
- Abstract IA02: Host microbiome interactions in health and disease (2020) (1)
- KL1 The inflammasome in health and disease (2010) (1)
- Faculty Opinions recommendation of A gut-brain neural circuit for nutrient sensory transduction. (2018) (1)
- 74 Amelioration of non-alcoholic steatohepatitis and glucose intolerance in OB/OB mice via oral immune regulation towards liver extracted proteins is associated with elevated intrahepatic NKT lymphocytes and a TH2 immune shift (2003) (1)
- Epigenetics and the Microbiome (2017) (1)
- Inflammasomes and Mucosal Immune Response (2013) (1)
- More reports of potential hepatotoxicity of Herbalife products: Reply (2008) (1)
- Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice (2020) (1)
- The Microbiota and Its Modulation in Immune-Mediated Disorders (2016) (1)
- Publisher Correction: Gut microbiota modulates weight gain in mice after discontinued smoke exposure (2022) (1)
- 692 Adoptive transfer of regulatory NKT lymphocytes ameliorates steatohepatitis and glucose intolerance in leptin-deficient mice (2003) (1)
- Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPARα suppression (2020) (1)
- Dendritic Cells 1 (2009) (1)
- Leptin receptor antagonists: preparation and use in research and medicine (2010) (0)
- Sanofi-Cell Research outstanding paper award of 2020 (2021) (0)
- Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention. (2021) (0)
- Nuclear Retention of mRNA in Mammalian Tissues Graphical (2015) (0)
- Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis (2022) (0)
- 9-OR: Personalized Diets by Prediction of Glycemic Responses Improve Glycemic Control in Subjects with Newly Diagnosed T2D (2021) (0)
- REROUTED, GENETICALLY MODIFIED regulatory T cells and their use for suppressing autoimmune inflammatory disease AND (2008) (0)
- DOP90 The role of Nlrp9b, a novel NLR member in regulating experimental colitis (2020) (0)
- CAR-T Cell Therapy and the Gut Microbiota (2023) (0)
- 791 Competitive Inhibition of Leptin Signaling By a Mutagenic Peptide Results in Amelioration of Acute Autoimmune Concanavalin a and Pseudomonas Exotoxin a Hepatitis (2008) (0)
- Trimming Trem2 and possible impacts on the metabolic syndrome (2022) (0)
- Response to Dr. Padda (2006) (0)
- FRI-297-Trans-signaling blockade induces mature-onset obesity and insulin resistance in mice via suppression of PPARalpha (2019) (0)
- Gut bacteria drive yo-yo dieting (2018) (0)
- Hierarchy of T cell lineage decision is regulated by thymic self-reactive signaling (36.45) (2010) (0)
- The intestinal microbiota fuelling metabolic inflammation (2019) (0)
- Affinity Leptins and Leptin Antagonists Development and Characterization of High Protein Structure and Folding (2014) (0)
- Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome (2015) (0)
- A microbial workout. (2023) (0)
- Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells (2016) (0)
- Small Intestinal Microbiota Oscillations, Host Effects and Regulation—A Zoom into Three Key Effector Molecules (2023) (0)
- No guts, no research glory (2019) (0)
- Redirected, genetically modified regulatory T cells and their use in the suppression of autoimmune and inflammatory diseases (2008) (0)
- TREIMM 1355 No . of Pages 13 Review NLRP 6 : A Multifaceted Innate Immune Sensor (2017) (0)
- Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells (2019) (0)
- Human microbiome research: Growing pains and future promises (2023) (0)
- The cancer microbiome (2019) (0)
- Fungi and cancer. (2023) (0)
- Faculty Opinions recommendation of The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. (2018) (0)
- P02.01 Predictive impact of the gut microbiota on treatment response to CD19 specific CAR T-cells (2020) (0)
- Inflammatory Mechanisms of Infection-Associated Cancer (2015) (0)
- Acute liver failure is regulated by MYC- and microbiome-dependent programs (2020) (0)
- The microbiota programs DNA methylation to control intestinal homeostasis and inflammation (2020) (0)
- Basic Biology of Rhythms and the Microbiome (2021) (0)
- Dietary fibers & immunity—more than meets the eye (2023) (0)
- Impact of caloric restriction on the gut microbiota. (2023) (0)
- Sieving through gut models of colonization resistance (2018) (0)
- Microbiota-dependent and -independent postnatal development of salivary immunity. (2023) (0)
- Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis (2022) (0)
- Correlation between serum alanine aminotransferase activity and age. Author's reply (2006) (0)
- The remedy within: will the microbiome fulfill its therapeutic promise? (2017) (0)
- Potential roles of gut microbiome and metabolites in modulating ALS in mice (2019) (0)
- No guts, no research glory (2019) (0)
- Inflammasomes and the microbiota—partners in the preservation of mucosal homeostasis (2014) (0)
- CD24 Plays an Important Role in CRC Carcinogenesis: The Azoxymethane (AOM)/Dextran Sulfate Sodium (DSS) Model in CD24 Knockout Mice (2011) (0)
- To Be Transmissible and Colitogenic IL-22 Deficiency Alters Colonic Microbiota (2013) (0)
- Diversifying nutritional sciences-dietary practices and gut bacteria in individuals of Latino and Hispanic ancestry. (2023) (0)
- Remembering past infections: training exercise for gut microbes (2021) (0)
- Interaction between microbiota and immunity in health and disease (2020) (0)
- Cell Metabolism Clinical and Translational Report Bread Affects Clinical Parameters and Induces Gut Microbiome-AssociatedPersonalGlycemicResponses (0)
- CASE REPORT Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus (2014) (0)
- Ex vivo intestinal permeability assay (X-IPA) for tracking barrier function dynamics (2022) (0)
- ANIMAL STUDIES ASSESSING THE MICROBIOME ROLES IN HYPERTENSION (2016) (0)
- Deciphering the Diet-Microbiome-Metabolism Axis (2017) (0)
- Dietary suppression of MHC-II expression in intestinal stem cells enhances intestinal tumorigenesis (2020) (0)
- Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients (2022) (0)
- Citrobacter rodentium Rel ies on Commensals for Colonization of the Colonic Mucosa Graphical (2017) (0)
- Designer fibre meals sway human gut microbes (2021) (0)
- Mo1802 Role of CD24 in the Development of DSS-Induced Murine Experimental Colitis (2012) (0)
This paper list is powered by the following services:
Other Resources About Eran Elinav
What Schools Are Affiliated With Eran Elinav?
Eran Elinav is affiliated with the following schools:
